CYCLOSPORINE OPHTHALMIC SOLUTION

CYCLOSPORINE OPHTHALMIC SOLUTION was reported 6159 times

CYCLOSPORINE OPHTHALMIC SOLUTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VOCAL CORD SCARRING 1 0.0909
1 EYELID DISCOLOURATION 4 0.0784
2 INSTILLATION SITE IRRITATION 91 0.0769
3 EYELID FOLLICULITIS 1 0.0556
4 INSTILLATION SITE HYPERSENSITIVITY 1 0.0435
5 EYE IRRITATION 2454 0.0426
6 INSTILLATION SITE PRURITUS 13 0.0345
7 INSTILLATION SITE FOREIGN BODY SENSATION 4 0.0276
8 CORNEAL IRRITATION 2 0.0250
9 INSTILLATION SITE DRYNESS 3 0.0233
10 OCULAR DISCOMFORT 243 0.0216
11 CONJUNCTIVAL DEPOSIT 1 0.0213
12 IATROGENIC KAPOSI SARCOMA 1 0.0204
13 INTRANASAL PARAESTHESIA 1 0.0200
14 INFLAMMATION OF LACRIMAL PASSAGE 1 0.0200
15 NEUROTROPHIC KERATOPATHY 1 0.0185
16 ABSCESS OF EYELID 1 0.0179
17 EYE PAIN 916 0.0162
18 PERIORBITAL DISCOMFORT 1 0.0156
19 FOREIGN BODY SENSATION IN EYES 96 0.0150
20 ADMINISTRATION SITE ODOUR 1 0.0132
21 EYE PRURITUS 407 0.0121
22 SWELLING OF NOSE 2 0.0116
23 OCULAR HYPERAEMIA 538 0.0113
24 HYPOAESTHESIA EYE 6 0.0102
25 EYELID IRRITATION 25 0.0100
26 ABNORMAL SENSATION IN EYE 39 0.0091
27 LACRIMATION INCREASED 272 0.0090
28 EYE DISCHARGE 93 0.0089
29 THERMAL BURNS OF EYE 2 0.0088
30 PERIORBITAL PAIN 7 0.0083
31 LACRIMATION DISORDER 1 0.0082
32 ADMINISTRATION SITE DISCOLOURATION 1 0.0080
33 PRODUCT DELIVERY MECHANISM ISSUE 43 0.0080
34 EYELID CYST 2 0.0077
35 SWELLING OF EYELID 48 0.0076
36 INSTILLATION SITE ERYTHEMA 4 0.0076
37 INSTILLATION SITE DISCOMFORT 1 0.0075
38 OPHTHALMIC MIGRAINE 5 0.0072
39 EYELID RASH 7 0.0072
40 HLA-B*27 POSITIVE 1 0.0071
41 DOSING ERROR 1 0.0060
42 DRY EYE 296 0.0059
43 INSTILLATION SITE SWELLING 1 0.0057
44 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 2 0.0055
45 EYELID MARGIN CRUSTING 15 0.0052
46 OCULAR PROCEDURAL COMPLICATION 1 0.0052
47 OCULAR ROSACEA 1 0.0049
48 IRIS HYPERPIGMENTATION 1 0.0048
49 NASAL CRUSTING 3 0.0046
50 PRODUCT CONTAMINATION CHEMICAL 1 0.0046
51 EYE SWELLING 159 0.0043
52 ERYTHEMA OF EYELID 23 0.0042
53 LACRIMATION DECREASED 2 0.0042
54 EYE INFLAMMATION 40 0.0042
55 INSTILLATION SITE PAIN 10 0.0040
56 GLARE 2 0.0039
57 ASTHENOPIA 21 0.0038
58 LAPAROSCOPY 1 0.0038
59 SPINAL FUSION ACQUIRED 1 0.0036
60 VISION BLURRED 479 0.0035
61 EAR INFLAMMATION 1 0.0035
62 EYELID PAIN 7 0.0034
63 CORNEAL INFILTRATES 1 0.0032
64 PERIORBITAL SWELLING 18 0.0032
65 PACKAGING DESIGN ISSUE 1 0.0030
66 PERIORBITAL IRRITATION 1 0.0029
67 PHOTOPHOBIA 55 0.0029
68 CHRONIC RESPIRATORY DISEASE 1 0.0028
69 EYE SYMPTOM 1 0.0028
70 LID SULCUS DEEPENED 1 0.0027
71 EYELIDS PRURITUS 8 0.0026
72 EYELID EXFOLIATION 2 0.0025
73 EYELID FUNCTION DISORDER 2 0.0025
74 CONJUNCTIVAL HAEMORRHAGE 9 0.0024
75 SYSTOLIC HYPERTENSION 1 0.0023
76 PRODUCT ODOUR ABNORMAL 24 0.0023
77 EYELID INFECTION 1 0.0023
78 HORDEOLUM 9 0.0021
79 DARK CIRCLES UNDER EYES 3 0.0020
80 DRAINAGE 1 0.0020
81 CORNEAL SCAR 1 0.0020
82 EYE COLOUR CHANGE 2 0.0020
83 EYE ALLERGY 3 0.0019
84 NASAL INFLAMMATION 2 0.0019
85 CORNEAL EROSION 1 0.0019
86 HALO VISION 2 0.0018
87 PRODUCT TEMPERATURE EXCURSION ISSUE 9 0.0017
88 PHOTOPSIA 11 0.0017
89 EYE ULCER 1 0.0017
90 OPTIC NERVE INJURY 2 0.0017
91 RESPIRATORY TRACT INFECTION VIRAL 4 0.0017
92 SINUS PAIN 4 0.0017
93 SPONDYLOARTHROPATHY 1 0.0017
94 EYELID SKIN DRYNESS 2 0.0016
95 CHALAZION 1 0.0016
96 INTESTINAL ANASTOMOSIS 1 0.0016
97 C-REACTIVE PROTEIN DECREASED 1 0.0015
98 SCLERAL DISCOLOURATION 1 0.0015
99 VITREOUS FLOATERS 15 0.0015
100 CORNEAL ABRASION 2 0.0015
101 BLEPHAROSPASM 9 0.0014
102 GLASSY EYES 1 0.0014
103 PRODUCT DESIGN ISSUE 1 0.0014
104 LARYNGEAL DISORDER 1 0.0014
105 LIQUID PRODUCT PHYSICAL ISSUE 10 0.0014
106 CONJUNCTIVITIS ALLERGIC 2 0.0013
107 CHROMATOPSIA 1 0.0013
108 RETINAL INJURY 1 0.0013
109 DRUG INEFFECTIVE 1688 0.0013
110 PRODUCT KNOWLEDGE DEFICIT 1 0.0013
111 PRODUCT INEFFECTIVE 1 0.0013
112 GOUTY ARTHRITIS 1 0.0013
113 LIP ERYTHEMA 1 0.0013
114 EYE INFECTION 14 0.0012
115 DYSCHROMATOPSIA 1 0.0012
116 ENDOCRINE OPHTHALMOPATHY 1 0.0012
117 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
118 CERUMEN IMPACTION 1 0.0011
119 COLOUR BLINDNESS 1 0.0011
120 VENOUS INJURY 1 0.0011
121 APPLICATION SITE DERMATITIS 1 0.0011
122 PRODUCT AFTER TASTE 1 0.0010
123 FOREIGN BODY IN EYE 1 0.0010
124 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
125 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
126 INFUSION SITE DISCOMFORT 1 0.0010
127 RESPIRATORY TRACT IRRITATION 1 0.0010
128 SUPERFICIAL INJURY OF EYE 1 0.0009
129 EYE DISORDER 30 0.0009
130 FACIAL PAIN 8 0.0009
131 BLOODY DISCHARGE 1 0.0009
132 EYELID DISORDER 2 0.0009
133 CONJUNCTIVAL HYPERAEMIA 3 0.0008
134 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
135 EAR DISCOMFORT 8 0.0008
136 HYPERSENSITIVITY 144 0.0008
137 LIP EXFOLIATION 1 0.0008
138 BLEPHARITIS 3 0.0007
139 SINUS CONGESTION 10 0.0007
140 RHINALGIA 2 0.0007
141 DISCHARGE 1 0.0007
142 NAIL INFECTION 1 0.0007
143 LIP PAIN 2 0.0007
144 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
145 STRABISMUS 2 0.0007
146 EXCESSIVE EYE BLINKING 1 0.0007
147 APRAXIA 1 0.0007
148 EYE INJURY 2 0.0007
149 PRODUCT USE COMPLAINT 10 0.0006
150 OPHTHALMOPLEGIA 1 0.0006
151 NASAL DISCOMFORT 5 0.0006
152 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
153 PRODUCT QUALITY ISSUE 85 0.0006
154 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
155 DIPLOPIA 16 0.0006
156 ADVERSE REACTION 8 0.0006
157 MEDICAL PROCEDURE 1 0.0006
158 LYME DISEASE 2 0.0006
159 EYE MOVEMENT DISORDER 4 0.0006
160 PERIORBITAL OEDEMA 3 0.0006
161 ADVERSE DRUG REACTION 50 0.0006
162 OPHTHALMIC HERPES ZOSTER 1 0.0006
163 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
164 MYDRIASIS 7 0.0005
165 SNEEZING 12 0.0005
166 MULTIPLE USE OF SINGLE-USE PRODUCT 3 0.0005
167 CYSTOID MACULAR OEDEMA 1 0.0005
168 PARANASAL SINUS DISCOMFORT 2 0.0005
169 IMPAIRED DRIVING ABILITY 6 0.0005
170 RADIOTHERAPY 1 0.0005
171 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
172 RHINORRHOEA 32 0.0005
173 CONDITION AGGRAVATED 145 0.0005
174 EYE CONTUSION 1 0.0005
175 OPTIC NEUROPATHY 1 0.0005
176 EAR SWELLING 1 0.0005
177 PRODUCT DISPENSING ISSUE 2 0.0005
178 SPUTUM INCREASED 1 0.0005
179 OCULAR ICTERUS 2 0.0005
180 CORNEAL DISORDER 1 0.0005
181 LIP SWELLING 15 0.0004
182 PRODUCT ADMINISTRATION ERROR 9 0.0004
183 READING DISORDER 1 0.0004
184 ORAL PRURITUS 1 0.0004
185 EYELID OEDEMA 5 0.0004
186 PUSTULE 1 0.0004
187 WRONG DOSE 1 0.0004
188 HAEMATOLOGICAL INFECTION 1 0.0004
189 PHARYNGEAL SWELLING 4 0.0004
190 THERAPY INTERRUPTED 29 0.0004
191 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
192 EYELID PTOSIS 4 0.0004
193 ILEOSTOMY 1 0.0004
194 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
195 LARYNGOSPASM 1 0.0004
196 VISUAL IMPAIRMENT 46 0.0004
197 BURNING SENSATION 26 0.0004
198 EAR CONGESTION 1 0.0004
199 BLOOD PHOSPHORUS INCREASED 1 0.0004
200 EOSINOPHILIC OESOPHAGITIS 1 0.0004
201 PRODUCT USE ISSUE 67 0.0004
202 DRUG TOLERANCE DECREASED 1 0.0004
203 PHARYNGEAL DISORDER 1 0.0003
204 PARAESTHESIA ORAL 5 0.0003
205 MOUTH SWELLING 2 0.0003
206 PRODUCT LABEL CONFUSION 2 0.0003
207 CATARACT OPERATION 2 0.0003
208 HEADACHE 209 0.0003
209 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
210 BLADDER PAIN 1 0.0003
211 INTRAOCULAR PRESSURE INCREASED 4 0.0003
212 DEAFNESS NEUROSENSORY 1 0.0003
213 PRODUCT FORMULATION ISSUE 2 0.0003
214 SINUS DISORDER 6 0.0003
215 HEPATIC FIBROSIS 1 0.0003
216 EAR PRURITUS 1 0.0003
217 PRODUCT CONTAMINATION 1 0.0003
218 NASAL CONGESTION 16 0.0003
219 CONJUNCTIVITIS 5 0.0003
220 HYPERACUSIS 1 0.0003
221 PAROSMIA 2 0.0003
222 DRUG INTOLERANCE 25 0.0003
223 BRAIN FOG 4 0.0003
224 MULTIPLE ALLERGIES 2 0.0003
225 GINGIVAL PAIN 2 0.0003
226 THROAT IRRITATION 11 0.0002
227 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
228 VISUAL ACUITY REDUCED 8 0.0002
229 PRODUCT CONTAINER ISSUE 2 0.0002
230 PSEUDOMONAS INFECTION 2 0.0002
231 POOR QUALITY SLEEP 5 0.0002
232 CHAPPED LIPS 1 0.0002
233 BONE CANCER 1 0.0002
234 TONGUE DISCOLOURATION 1 0.0002
235 DIVERTICULUM INTESTINAL 1 0.0002
236 GINGIVAL SWELLING 1 0.0002
237 EYE HAEMORRHAGE 3 0.0002
238 EXTRA DOSE ADMINISTERED 9 0.0002
239 THROAT TIGHTNESS 6 0.0002
240 LIP DRY 2 0.0002
241 URINE ABNORMALITY 1 0.0002
242 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
243 EAR DISORDER 1 0.0002
244 ORAL DISCOMFORT 3 0.0002
245 PRESCRIBED UNDERDOSE 4 0.0002
246 BRAIN INJURY 2 0.0002
247 MIGRAINE 19 0.0002
248 DRY THROAT 2 0.0002
249 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
250 POLYARTHRITIS 1 0.0002
251 FACE OEDEMA 3 0.0002
252 COLECTOMY 1 0.0002
253 DERMATITIS CONTACT 2 0.0002
254 HERPES VIRUS INFECTION 1 0.0002
255 URINE ODOUR ABNORMAL 1 0.0002
256 HEAD DISCOMFORT 3 0.0002
257 SWELLING FACE 11 0.0002
258 SINUS HEADACHE 1 0.0002
259 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
260 DYSGEUSIA 12 0.0002
261 INFUSION SITE EXTRAVASATION 1 0.0002
262 PRE-EXISTING CONDITION IMPROVED 1 0.0002
263 SWOLLEN TONGUE 5 0.0002
264 NASAL DRYNESS 1 0.0002
265 THERAPEUTIC RESPONSE CHANGED 1 0.0002
266 HAEMOGLOBIN ABNORMAL 1 0.0002
267 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
268 DEAFNESS 4 0.0002
269 TINNITUS 7 0.0002
270 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
271 TASTE DISORDER 3 0.0001
272 PRODUCT TASTE ABNORMAL 2 0.0001
273 ONYCHOCLASIS 1 0.0001
274 RESPIRATION ABNORMAL 1 0.0001
275 EXTRASYSTOLES 1 0.0001
276 VISUAL FIELD DEFECT 1 0.0001
277 RASH PUSTULAR 1 0.0001
278 DISCOMFORT 8 0.0001
279 ADVERSE EVENT 12 0.0001
280 DIZZINESS 64 0.0001
281 TREATMENT NONCOMPLIANCE 7 0.0001
282 INTENTIONAL PRODUCT MISUSE 11 0.0001
283 PRURITUS 48 0.0001
284 MYASTHENIA GRAVIS 1 0.0001
285 MUSCLE TIGHTNESS 2 0.0001
286 PRODUCT COMPLAINT 3 0.0001
287 SKIN HYPERPIGMENTATION 1 0.0001
288 GRIP STRENGTH DECREASED 1 0.0001
289 PALPITATIONS 13 0.0001
290 LUPUS-LIKE SYNDROME 1 0.0001
291 INCREASED TENDENCY TO BRUISE 1 0.0001
292 OROPHARYNGEAL PAIN 10 0.0001
293 PRODUCT DISTRIBUTION ISSUE 1 0.0001
294 EPISTAXIS 8 0.0001
295 BLOOD SODIUM DECREASED 2 0.0001
296 LEUKAEMIA 1 0.0001
297 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
298 PRODUCT PACKAGING ISSUE 1 0.0001
299 RECALLED PRODUCT ADMINISTERED 1 0.0001
300 RASH ERYTHEMATOUS 5 0.0001
301 DIZZINESS POSTURAL 1 0.0001
302 THERAPY CHANGE 1 0.0001
303 INABILITY TO AFFORD MEDICATION 1 0.0001
304 THERAPEUTIC RESPONSE DECREASED 6 0.0001
305 BLOOD PRESSURE INCREASED 15 0.0001
306 TEMPERATURE INTOLERANCE 1 0.0001
307 POOR VENOUS ACCESS 1 0.0001
308 JOINT DISLOCATION 1 0.0001
309 PHARYNGITIS STREPTOCOCCAL 1 0.0001
310 INCORRECT DOSE ADMINISTERED 21 0.0001
311 PRODUCT DISPENSING ERROR 2 0.0001
312 RASH 40 0.0001
313 APPLICATION SITE PAIN 2 0.0001
314 URTICARIA 15 0.0001
315 ORAL PAIN 2 0.0001
316 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
317 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
318 SINUSITIS 9 0.0001
319 GASTRIC HAEMORRHAGE 1 0.0001
320 DRY MOUTH 7 0.0001
321 MADAROSIS 1 0.0001
322 DYSPHONIA 5 0.0001
323 SKIN EXFOLIATION 7 0.0001
324 PRESYNCOPE 2 0.0001
325 PRODUCT DOSE OMISSION ISSUE 24 0.0001
326 SPINAL OPERATION 1 0.0001
327 INJECTION SITE DISCOLOURATION 1 0.0001
328 PRODUCT STORAGE ERROR 7 0.0001
329 FLUSHING 8 0.0001
330 ORAL CANDIDIASIS 1 0.0001
331 RASH PRURITIC 4 0.0001
332 CARPAL TUNNEL SYNDROME 1 0.0001
333 BLINDNESS UNILATERAL 1 0.0001
334 PAIN IN JAW 2 0.0001
335 DIALYSIS 1 0.0001
336 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
337 INTENTIONAL DOSE OMISSION 2 0.0001
338 BALANCE DISORDER 6 0.0001
339 GASTROENTERITIS 1 0.0001
340 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
341 CATARACT 4 0.0001
342 IMMUNODEFICIENCY 1 0.0001
343 FEELING ABNORMAL 16 0.0001
344 VERTIGO 4 0.0001
345 INSURANCE ISSUE 1 0.0001
346 HIP ARTHROPLASTY 1 0.0001
347 THERAPY PARTIAL RESPONDER 1 0.0001
348 DYSPHAGIA 6 0.0001
349 SCIATICA 1 0.0001
350 NIGHT SWEATS 2 0.0001
351 PHOTOSENSITIVITY REACTION 1 0.0001
352 VIRAL INFECTION 2 0.0001
353 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
354 ILLNESS 6 0.0001
355 NERVOUSNESS 3 0.0001
356 ECZEMA 3 0.0001
357 DEVICE USE ISSUE 1 0.0001
358 THIRST 1 0.0001
359 TOOTHACHE 1 0.0001
360 ACCIDENTAL OVERDOSE 2 0.0001
361 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
362 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
363 BLOOD GLUCOSE ABNORMAL 1 0.0001
364 HEPATIC STEATOSIS 1 0.0001
365 THINKING ABNORMAL 1 0.0001
366 ERYTHEMA 11 0.0001
367 HOT FLUSH 4 0.0001
368 FEELING JITTERY 1 0.0001
369 DRY SKIN 7 0.0001
370 SLEEP APNOEA SYNDROME 1 0.0001
371 LETHARGY 3 0.0001
372 GLAUCOMA 1 0.0001
373 EAR PAIN 1 0.0001
374 CHOKING 1 0.0001
375 SURGERY 3 0.0001
376 SKIN FISSURES 1 0.0001
377 KIDNEY INFECTION 1 0.0001
378 HEART RATE INCREASED 5 0.0001
379 INJECTION SITE BRUISING 4 0.0001
380 COUGH 14 0.0000
381 MUSCLE SPASMS 9 0.0000
382 PRODUCT PREPARATION ERROR 1 0.0000
383 TREATMENT FAILURE 4 0.0000
384 DERMATITIS 1 0.0000
385 KNEE ARTHROPLASTY 1 0.0000
386 LIVER FUNCTION TEST INCREASED 1 0.0000
387 DEVICE DIFFICULT TO USE 3 0.0000
388 ANGIOEDEMA 2 0.0000
389 INSOMNIA 12 0.0000
390 GLOSSODYNIA 1 0.0000
391 GASTROINTESTINAL DISORDER 4 0.0000
392 NO ADVERSE EVENT 8 0.0000
393 SKIN IRRITATION 2 0.0000
394 SKIN DISCOLOURATION 2 0.0000
395 MUSCLE TWITCHING 1 0.0000
396 PERICARDIAL EFFUSION 1 0.0000
397 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
398 ARRHYTHMIA 2 0.0000
399 PRODUCT PRESCRIBING ERROR 1 0.0000
400 PRODUCTIVE COUGH 2 0.0000
401 JOINT SWELLING 5 0.0000
402 LOCALISED INFECTION 1 0.0000
403 UNDERDOSE 3 0.0000
404 INJECTION SITE URTICARIA 1 0.0000
405 CHEST DISCOMFORT 4 0.0000
406 THERAPY CESSATION 2 0.0000
407 EXPOSURE VIA SKIN CONTACT 1 0.0000
408 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
409 PAIN OF SKIN 1 0.0000
410 PNEUMONITIS 1 0.0000
411 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
412 SKIN LESION 1 0.0000
413 DIVERTICULITIS 1 0.0000
414 MEDICATION ERROR 2 0.0000
415 NECK PAIN 2 0.0000
416 WOUND 1 0.0000
417 DYSPNOEA 20 0.0000
418 URINARY TRACT INFECTION 6 0.0000
419 DYSSTASIA 1 0.0000
420 NAUSEA 27 0.0000
421 TACHYCARDIA 3 0.0000
422 URINARY INCONTINENCE 1 0.0000
423 WHEEZING 2 0.0000
424 BLOOD POTASSIUM DECREASED 1 0.0000
425 INJECTION SITE RASH 1 0.0000
426 NASOPHARYNGITIS 6 0.0000
427 PARAESTHESIA 5 0.0000
428 HEAD INJURY 1 0.0000
429 CYSTITIS 1 0.0000
430 CONTUSION 3 0.0000
431 STAPHYLOCOCCAL INFECTION 1 0.0000
432 TREMOR 5 0.0000
433 EXPIRED PRODUCT ADMINISTERED 1 0.0000
434 URINARY RETENTION 1 0.0000
435 ARTHRALGIA 12 0.0000
436 RASH MACULAR 1 0.0000
437 FATIGUE 22 0.0000
438 LYMPHADENOPATHY 1 0.0000
439 SKIN BURNING SENSATION 2 0.0000
440 CONSTIPATION 6 0.0000
441 RESTLESSNESS 1 0.0000
442 INJECTION SITE MASS 1 0.0000
443 HYPOAESTHESIA 4 0.0000
444 ASTHMA 3 0.0000
445 PAIN 16 0.0000
446 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
447 DISORIENTATION 1 0.0000
448 SOMNOLENCE 5 0.0000
449 DEVICE BREAKAGE 1 0.0000
450 ANXIETY 7 0.0000
451 BLINDNESS 1 0.0000
452 INFLUENZA LIKE ILLNESS 2 0.0000
453 ABDOMINAL DISCOMFORT 4 0.0000
454 OSTEOARTHRITIS 1 0.0000
455 HYPOACUSIS 1 0.0000
456 DEVICE LEAKAGE 1 0.0000
457 COVID-19 4 0.0000
458 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
459 THERAPY NON-RESPONDER 1 0.0000
460 SWELLING 2 0.0000
461 DISEASE RECURRENCE 1 0.0000
462 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
463 LUNG DISORDER 1 0.0000
464 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
465 SYNCOPE 2 0.0000
466 ABDOMINAL PAIN UPPER 4 0.0000
467 VOMITING 9 0.0000
468 DERMATITIS ATOPIC 1 0.0000
469 HYPERTENSION 4 0.0000
470 BRADYCARDIA 1 0.0000
471 DISTURBANCE IN ATTENTION 1 0.0000
472 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
473 ANAPHYLACTIC REACTION 1 0.0000
474 INFLUENZA 2 0.0000
475 BLISTER 1 0.0000
476 HERPES ZOSTER 1 0.0000
477 PRODUCT SUBSTITUTION ISSUE 1 0.0000
478 DECREASED APPETITE 4 0.0000
479 BONE PAIN 1 0.0000
480 CHILLS 2 0.0000
481 PAIN IN EXTREMITY 5 0.0000
482 STOMATITIS 1 0.0000
483 ILL-DEFINED DISORDER 1 0.0000
484 FEELING HOT 1 0.0000
485 INJECTION SITE PAIN 5 0.0000
486 CHEST PAIN 3 0.0000
487 INJECTION SITE ERYTHEMA 2 0.0000
488 BLOOD GLUCOSE INCREASED 3 0.0000
489 LOSS OF CONSCIOUSNESS 2 0.0000
490 HYPERHIDROSIS 2 0.0000
491 ALOPECIA 3 0.0000
492 OFF LABEL USE 13 0.0000
493 INJECTION SITE REACTION 1 0.0000
494 DEVICE MALFUNCTION 1 0.0000
495 SLEEP DISORDER 1 0.0000
496 OVERDOSE 3 0.0000
497 INFECTION 2 0.0000
498 UNEVALUABLE EVENT 1 0.0000
499 HOSPITALISATION 2 0.0000
500 PERIPHERAL SWELLING 2 0.0000
501 BACK PAIN 3 0.0000
502 ARTHRITIS 1 0.0000
503 DRUG INTERACTION 2 0.0000
504 CARDIAC FAILURE CONGESTIVE 1 0.0000
505 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
506 CARDIAC DISORDER 1 0.0000
507 ANAEMIA 2 0.0000
508 DYSPEPSIA 1 0.0000
509 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
510 DIARRHOEA 6 0.0000
511 MALAISE 4 0.0000
512 FALL 3 0.0000
513 RHEUMATOID ARTHRITIS 1 0.0000
514 MUSCULAR WEAKNESS 1 0.0000
515 ABDOMINAL PAIN 2 0.0000
516 DISEASE PROGRESSION 1 0.0000
517 EMOTIONAL DISTRESS 1 0.0000
518 OEDEMA PERIPHERAL 1 0.0000
519 ASTHENIA 3 0.0000
520 PSORIASIS 1 0.0000
521 MEMORY IMPAIRMENT 1 0.0000
522 WEIGHT DECREASED 2 0.0000
523 CONFUSIONAL STATE 1 0.0000
524 MYALGIA 1 0.0000
525 DEATH 5 0.0000
526 WEIGHT INCREASED 1 0.0000
527 DEPRESSION 1 0.0000
528 PNEUMONIA 1 0.0000